Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Motor Activity 1Melanoma 1Malnutrition 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Body Weight 1

Interventions

Metformin 7Clomiphene 4Progesterone 2Pioglitazone 2Medroxyprogesterone Acetate 2Inositol 2Folic Acid 2Flutamide 2Estrogens 2Estradiol 2salicylsalicylic acid 1ganirelix 1Thioctic Acid 1Sugars 1Resistance Training 1Raloxifene Hydrochloride 1Progestins 1Nutrition Assessment 1Methyltestosterone 1Magnesium 1Linseed Oil 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Gonadotropins 1Flour 1Fenofibrate 1Exercise 1Docosahexaenoic Acids 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Polycystic Ovary Syndrome × Diet Therapy × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡